BioSpace News Archive

Business

Vericel to Report Second-Quarter 2023 Financial Results on August 2, 2023

Vericel Corporation today announced that it will report its second-quarter 2023 financial results on Wednesday, August 2, 2023.

July 20, 2023
·
1 min read
Drug Development

Recce Pharmaceuticals Achieves Positive Phase I Clinical Trial Data of RECCE® 327 as an Intravenous Infusion Formulation

Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) (the Company), the Company developing a new class of synthetic anti-infectives, today announced positive results from a Phase I (R327-001) study of RECCE® 327 (R327) as an intravenous (IV) infusion formulation in 80 healthy male subjects.

July 20, 2023
·
10 min read
Pharm Country

Rarecells, Inc. announces a breakthrough publication on Circulating Giant Cancer Cells detected in patients with MDS

Rarecells is thrilled to announce its breakthrough publication, written in partnership with the team of Dr. Azra Raza from Columbia University Irving Medical Center, revealing for the first time the presence of circulating giant cancer cells (CGCCs) in patients with Myelodysplastic Syndrome (MDS).

July 20, 2023
·
2 min read
Deals

Sorrento Therapeutics, Inc.'s Bankruptcy Court Approves Elective Offering of Restricted Common Stock of Scilex Holding Company for Dividend Short Holders

Sorrento Therapeutics, Inc. announced that, in connection with its ongoing chapter 11 case, the U.S. Bankruptcy Court for the Southern District of Texas entered an order approving an offering of a portion of Sorrento’s common stock in its non-debtor public subsidiary, Scilex Holding Company.

July 20, 2023
·
6 min read
Business

Zynex, Inc. Sets Second Quarter 2023 Earnings Call

Zynex, Inc. will hold a conference call on Thursday, July 27, 2023 at 4:15 PM Eastern Time to discuss its financial results for the second quarter, 2023 ended June 30, 2023.

July 20, 2023
·
1 min read